Teva Pharmaceuticals USA is recalling approximately 213,149 units of several injectable medications, including Leucovorin Calcium, Haloperidol Decanoate, Methylprednisolone Acetate, and Metoclopramide. These products are being recalled because the company cannot guarantee they are sterile, which is a critical safety requirement for injected drugs. Consumers who have received these medications should be aware that the recall affects multiple lot numbers distributed nationwide.
A lack of sterility assurance in injectable medications can lead to serious systemic infections or localized site reactions if the product is contaminated with bacteria or fungi. While no specific injuries or infections have been reported in this notice, the risk is elevated because these drugs are administered directly into the body via intramuscular or intravenous injection.
Refund and Healthcare Consultation
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.